Navigation Links
Infant toenails reveal in utero exposure to low-level arsenic, Dartmouth study finds
Date:7/7/2014

Infant toenails are a reliable way to estimate arsenic exposure before birth, a Dartmouth College study shows.

The findings appear in the Journal of Exposure Science & Environmental Epidemiology. A PDF of the study is available on request.

A growing body of evidence suggests that in utero and early-life exposure to arsenic may have detrimental effects on children, even at the low to moderate levels common in the United States and elsewhere. The fetus starts to develop toenails during the first trimester, making them an accurate measure of exposure to arsenic during the entire gestation. Prior studies that used infant toenails as a biomarker of in utero exposure were conducted in highly exposed populations.

But in a sample of 170 motherinfant pairs from New Hampshire, the researchers determined infant exposure to relatively low arsenic in utero by evaluating infant toenails as a biomarker using plasma mass spectrometry.

The results show that a doubling of maternal postpartum toenail arsenic concentration was associated with a 54 percent increase in infant toenail arsenic concentration as compared with 20 percent for a doubling of maternal urine arsenic concentration. Also, a doubling of maternal toenail and urine arsenic concentrations was associated with a 68 percent increase in infant toenail arsenic concentration. A similar correlation between infant and maternal postpartum toenail concentrations was observed in a group of 130 motherinfant pairs from Rhode Island.

"In utero exposure to arsenic occurs through maternal drinking water and dietary sources, and infant toenails appear to be a reliable biomarker for estimating arsenic exposure during the critical window of gestation," says senior author Professor Margaret Karagas.


'/>"/>

Contact: John Cramer
John.Cramer@Dartmouth.edu
603-646-9130
Dartmouth College
Source:Eurekalert

Page: 1

Related medicine news :

1. Depressed moms behavior may play role in infants sleep problems
2. Research shows efficacy of treatment model developed at Women & Infants
3. New Techniques May Improve Infant Heart Surgery
4. Low-Income Mothers May Overfeed Their Infants
5. Gut flora affects maturation of B cells in infants
6. Phthalates in PVC floors taken up by the body in infants
7. Hazelnuts: New source of key fat for infant formula thats more like mothers milk
8. Disease that stunts infants growth traced to same gene that makes kids grow too fast
9. Infant Smarts Similar With Different Types of Formula: Study
10. Infant Vaccination Delays Triple in Oregon: Study
11. Infants cant distinguish between large and small groups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association ... standards of excellence for the field of eating disorders, announces the opening of ... 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. , ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 ... mobile health and big data solutions, today announced that its MyDario product ... check your local TV listings for when The Dr. Oz Show airs ... The ... this month. ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology: